Prostate size ≥ 100 g and its association with long-term outcomes of Retzius-sparing robot-assisted radical prostatectomy.
Ofir MaltzmanStefano TapperoAlberto CavigliaErika PalagoniaCarlo BurattoFrancesco ChierigoValerio CelliniAlberto OliveroMichele BarbieriSilvia SeccoAldo Massimo BocciardiAntonio GalfanoPaolo Dell'OglioPublished in: World journal of urology (2024)
RS-RARP is a valid option for prostate cancer treatment, even in case of very large prostates. Specifically, no significant association was recognized between PS ≥ 100 g and PSM or 12-month UCR.